About

Our international network offers you a world of expertise from API development to commercial manufacture – and beyond – supported and managed anywhere in the world.

Here to Help

Aesica has the capabilities and expertise to facilitate your product development at any stage. We can take your product from early development to commercialisation – or provide specific services as one-offs – with processes customised to suit your company, output and brand vision.

CONSORT MEDICAL PLC, HEMEL HEMPSTEAD, UK

Consort Medical plc
Suite B, Breakspear Park
Breakspear Way
Hemel Hempstead
Hertfordshire
HP2 4TZ
Tel: +44 (0) 1442 867 920
Fax: +44 (0) 1442 245 237
Website: http://consortmedical.com/

Hemel Hempstead is the Head Office for the Group.

Newcastle-upon-Tyne, UK

Cobalt imageAesica Pharmaceuticals Limited
Equinox House
3.2 Silver Fox Way
Cobalt Business Park
Newcastle Upon Tyne
NE27 0QJ
United Kingdom
Tel: +44 (0) 191 296 0655
Fax: +44 (0)191 266 9447

Cramlington, UK

Aesica Pharmaceuticals Limited
Windmill Industrial Estate
Shotton Lane
Cramlington
Northumberland
NE23 3JL
United Kingdom
Tel: +44 (0)1670 590595
Fax: +44 (0)1670 597360

Our Cramlington site has over 25 years’ experience in the manufacturing of APIs and we are experts in process scale up and technology transfer with a focus on safety, quality and regulatory compliance.

Multi-purpose site for:

  • Development capabilities
  • Kilo lab
  • Pilot scale
  • Commercial scale plants
  • Generic API supply
  • Potent drugs and controlled substances

Authority approvals include:

MHRA, FDA, ISO 14001, ISO 9001, possession of controlled drugs and manufacture of controlled drugs.

Queenborough, UK

Aesica Queenborough Limited
North Road
Queenborough
Kent
ME11 5EL
United Kingdom
Tel: +44 (0)1795 543000
Fax: +44 (0)1795 543335

Queenborough offers both finished dose and API services and has successfully expanded the customer portfolio and offers a broad range of technologies.

Multi-purpose site for:

    • 3 billion+ tablet capacity
    • 1.5 million litres of liquid capacity
    • 98 bulk products
    • 12 APIs
    • API manufacturing services
    • Liquids and solid dose manufacturing and packaging
    • Blisters, bottles (solid dose, granules, oral liquids, anaesthetics), sachets
    • Analytical and development capabilities
    • Potent drug capability for manufacturing and packaging (liquids/solids)
    • Controlled drug manufacturing and packaging
    • Continuous manufacturing technology
    • Storage capabilities including cold and controlled drug
    • Stand alone development facility
    • Formulation development for oral, liquid, topical and inhaled products
    • Analytical method development
    • ICH stability testing
    • Clinical trial manufacture Phase I-III clinical manufacturing capability and QP release
    • Specialists in cytotoxics, high potency and controlled drugs
    • Embraces newer technologies
    • Artwork services

    MHRA, EU, FDA, Korean FDA, PMDA, ANVISA, ROW, QP release, possession of controlled drugs and manufacture of controlled drugs.

Monheim, Germany

Aesica Pharmaceuticals GmbH
Alfred-Nobel- Straße 10
40789 Monheim
Germany
Tel: +49 2173 335 0
Fax: +49 2173 335 1020

Integrated packaging and distribution capabilities for blisters, bottles, sachets and pouches and artwork services.

Packaging site for:

  • A broad range of dose forms including syringes and pouches
  • Over 200 products/1500+ SKUs
  • Bulk importation and EU release testing
  • Multi country packaging and repackaging services
  • Analytical development
  • Stability with all ICH zones
  • QP release of final products to market
  • Distribution and logistics

Authority approvals include:

EU, FDA, Korean FDA, ANVISA, ROW, Gulf Country Council and QP release

Zwickau, Germany

Aesica Pharmaceuticals GmbH
Galileistraße 6
08056 Zwickau
Germany
Tel: 49 375 322 0
Fax: +49 375 322 585

Bulk production site excelling in solid dosage forms and offering a full spectrum of analytical and development capabilities.

Multi-purpose site for:

  • 3 billion+ capacity
  • 98 bulk products
  • 12 APIs
  • Pellet production
  • Hard gelatine capsules
  • Analytical and development capabilities

Authority approvals include:

EU, FDA, Korean FDA, PDMA, ANVISA, ROW, Gulf Country Council and QP release

Pianezza, Italy

Aesica Pharmaceuticals S.r.I.
Sede legale: Via Praglia,15
10044 Pianezza (TO)
Italy
Tel: +39 011 9660 1
Fax: +39 011 9660 244

Commercial scale manufacture of liquid products: both terminally sterilised injectables (vials and ampoules) and oral liquids. Blister packaging with fully automated flexible packaging lines and analytical capabilities.

Multi-purpose site for:

  • Manufacturing: injectables and oral liquid finished dose forms
  • Packaging: oral solid, oral liquid and injectable forms
  • Analytical capabilities and QP release

Authority approvals include:

EU, PMDA, AIFA, ANVISA, ROW, QP release, ISO 14001and ISO 9001